Table 3.

Absolute and incremental costs, effect and cost-effectiveness from the patients, health facilities and the TB program perspective. For both strategies, incremental values are calculated compared to a common baseline, i.e. no case finding

Strategy	Cost/health seeker for symptoms of TB (USD)	Incremental Cost	DALYs	Incremental DALYs	Incremental C/E
No passive case finding	0		0.1806
Passive case finding	6.09	6.09	0.0491	0.1315	46.27
No active case finding	0		0.1806
Active case finding	2.67	2.67	0.0107	0.1699	15.74

The DALY is a negative outcome measure, meaning that less are better than more. Thus, the DALYs were inverted for computational reasons in this analysis